"Quality improvement measures and focused pathological staging without adjuvant chemotherapy in stage II colon cancer: interim results from a National Cancer Institute sponsored international prospective multi-center trial" by Anton J. Bilchik

Selected Works of Anton J Bilchik, MD, PhD, MBA, FACS

Article

Quality improvement measures and focused pathological staging without adjuvant chemotherapy in stage II colon cancer: interim results from a National Cancer Institute sponsored international prospective multi-center trial

Journal of The American College of Surgeons (2014)

Anton J. Bilchik
Mladjan Protic
Aviram Nissan
Zev Wainberg
Scott R. Steele
Itzhak Avital
Alexander Stojadinovic

Link

Disciplines

Medicine and Health Sciences and
Surgery

Publication Date

October 1, 2014

DOI

10.1016/j.jamcollsurg.2014.07.502

Citation Information

Anton J. Bilchik, Mladjan Protic, Aviram Nissan, Zev Wainberg, et al.. "Quality improvement measures and focused pathological staging without adjuvant chemotherapy in stage II colon cancer: interim results from a National Cancer Institute sponsored international prospective multi-center trial" Journal of The American College of Surgeons Vol. 219 Iss. 4 (2014)
Available at: http://works.bepress.com/antonj-bilchik/37/